Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Expro Ltd
XPRO
$2.1B
| $5.74M | ﹤0.01% |
184,966
+5,260
| +3% | +$161K |
|
1952
Century Aluminum
CENX
$4.59B
| $5.73M | ﹤0.01% |
762,707
+48,752
| +7% | +$338K |
|
1953
Cohu
COHU
$2.76B
| $5.73M | ﹤0.01% |
250,616
+6,079
| +2% | +$109K |
|
|
COOP
1954
DELISTED
Mr. Cooper
COOP
| $5.7M | ﹤0.01% |
455,593
+7,678
| +2% | +$94.3K |
|
|
UCTT
1955
Ultra Clean Holdings
UCTT
$4.21B
| $5.7M | ﹤0.01% |
242,815
+3,599
| +2% | +$72.8K |
|
1956
TG Therapeutics
TGTX
$7.34B
| $5.7M | ﹤0.01% |
513,048
+45,399
| +10% | +$345K |
|
1957
iQIYI
IQ
$1.31B
| $5.69M | ﹤0.01% |
269,713
+108,559
| +67% | +$2M |
|
1958
iShares Micro-Cap ETF
IWC
$1.5B
| $5.68M | ﹤0.01% |
57,075
| – | – |
|
|
CIR
1959
DELISTED
CIRCOR International, Inc
CIR
| $5.65M | ﹤0.01% |
122,127
+4,249
| +4% | +$176K |
|
|
CISN
1960
DELISTED
Cision Ltd. Ordinary Share
CISN
| $5.59M | ﹤0.01% |
560,245
-1,150
| -0.2% | -$11K |
|
|
DPLO
1961
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $5.57M | ﹤0.01% |
1,392,674
+297,245
| +27% | +$1.4M |
|
1962
Liberty Media Series A
FWONA
$23.7B
| $5.57M | ﹤0.01% |
132,788
+6,314
| +5% | +$248K |
|
1963
ProPetro Holding
PUMP
$1.42B
| $5.55M | ﹤0.01% |
493,668
+9,294
| +2% | +$83.1K |
|
1964
Extreme Networks
EXTR
$3.16B
| $5.55M | ﹤0.01% |
753,206
-295,172
| -28% | -$2.07M |
|
1965
Ennis
EBF
$559M
| $5.53M | ﹤0.01% |
255,519
+4,580
| +2% | +$93.1K |
|
1966
Koppers
KOP
$874M
| $5.5M | ﹤0.01% |
143,752
+20,661
| +17% | +$726K |
|
1967
CareDx
CDNA
$2.45B
| $5.49M | ﹤0.01% |
254,410
-9,820
| -4% | -$225K |
|
|
IVC
1968
DELISTED
Invacare Corporation
IVC
| $5.49M | ﹤0.01% |
608,100
-85,868
| -12% | -$722K |
|
1969
Triumph Financial Inc
TFIN
$1.87B
| $5.48M | ﹤0.01% |
144,236
-3,208
| -2% | -$111K |
|
1970
ADT
ADT
$5.46B
| $5.48M | ﹤0.01% |
690,792
+18,664
| +3% | +$147K |
|
|
FOCS
1971
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $5.48M | ﹤0.01% |
185,834
+2,457
| +1% | +$62.8K |
|
1972
Arbor Realty Trust
ABR
$981M
| $5.47M | ﹤0.01% |
381,465
+54,026
| +16% | +$768K |
|
|
LTRPA
1973
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $5.47M | ﹤0.01% |
743,948
+67,169
| +10% | +$541K |
|
1974
Atara Biotherapeutics
ATRA
$76.7M
| $5.47M | ﹤0.01% |
13,276
+327
| +3% | +$113K |
|
1975
German American Bancorp
GABC
$1.92B
| $5.46M | ﹤0.01% |
153,122
+2,691
| +2% | +$90K |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.